The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics

od Long, Stephen B., Hancock, Paula J., Kral, Astrid M., Hellinga, Homme W., Beese, Lorena S.
Wydane 2001

Quantitative evaluation of siRNA delivery in vivo

od Pei, Yi, Hancock, Paula J., Zhang, Hangchun, Bartz, René, Cherrin, Craig, Innocent, Nathalie, Pomerantz, Colin J., Seitzer, Jessica, Koser, Martin L., Abrams, Marc T., Xu, Yan, Kuklin, Nelly A., Burke, Paul A., Sachs, Alan B., Sepp-Lorenzino, Laura, Barnett, Stanley F.
Wydane 2010

Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors

od Barnett, Stanley F., Defeo-Jones, Deborah, Fu, Sheng, Hancock, Paula J., Haskell, Kathleen M., Jones, Raymond E., Kahana, Jason A., Kral, Astrid M., Leander, Karen, Lee, Ling L., Malinowski, John, McAVOY, Elizabeth M., Nahas, Debbie D., Robinson, Ronald G., Huber, Hans E.
Wydane 2005

Discovery of an Anion-Dependent Farnesyltransferase Inhibitor from a Phenotypic Screen

od Bukhtiyarova, Marina, Cook, Erica M., Hancock, Paula J., Hruza, Alan W., Shaw, Anthony W., Adam, Gregory C., Barnard, Richard J. O., McKenna, Philip M., Holloway, M. Katharine, Bell, Ian M., Carroll, Steve, Cornella-Taracido, Ivan, Cox, Christopher D., Kutchukian, Peter S., Powell, David A., Strickland, Corey, Trotter, B. Wesley, Tudor, Matthew, Wolkenberg, Scott, Li, Jing, Tellers, David M.
Wydane w ACS Med Chem Lett (2020)